This protocol is judged by an institutional evaluation board, an impartial team that reviews any medical trials involving human beings. If a review involves a Timetable I drug, when the board approves the protocol as ethical, the scientists should apply for an investigational new drug (IND) quantity with the FDA.Medicines might also contain uniden